You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Merck
since
auto-detected in 42 stories
18 days ago
These are the stocks posting the largest moves premarket.
40 days ago
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook ⊕
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
60 days ago
Merck shares are forming a bullish chart pattern, and a breakout could be on the horizon ⊕
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
76 days ago
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline ⊖⊖
Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
77 days ago
Merck nears $6bn biotech deal to boost cancer drug pipeline ⊖
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
3 months ago
Merck to create separate cancer business to offset Keytruda patent loss ⊖⊖
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
4 months ago
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms ⊕
Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more ○
These are the stocks posting the largest moves in early trading.
Investor Joe Terranova likes Merck despite pharmaceutical firm's move to lower drug price ⊕
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes drug has impacted its business.
Merck in talks to buy cancer drugmaker Revolution Medicines ⊖⊖
US drug company is seeking to acquire the maker of a new treatment for pancreatic cancer